Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 exploratory study of selexipag (NS-304) in Japanese pediatric patients with pulmonary arterial hypertension
jRCT2080225295Phase 4Completed
- Sponsor
- Nippon Shinyaku
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of selexipag in pulmonary arterial hypertension (PAH), sponsored by Nippon Shinyaku. Started Jul 2020; status: completed.
02
Drugs
selexipag
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on jRCT2080225295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225295.